Department of Medicinal Chemistry, GlaxoSmithKline, RTP, NC 27709, USA. cja9377@gsk.com
Abstract:
A series of bis-aryl substituted guanidines have been discovered as potent NPY Y5 antagonists. The SAR and in vitro metabolic stability of these compounds are discussed.